Clinical Development
| ACE Pharmaceuticals | ||
Our laboratory is a certified, independently operating analytical laboratory, providing advanced and sophisticated analytical services with experienced professionals and state-of-the-art instrumentation. |
Analysis of active ingredients as such, in blends and finished products such as soft and hard gel caps, tablets and capsules. |
Primary packaging - bottling of tablets and capsules. |
ACE's up-to-date premises for the manufacturing of clinical trial medication. |
||
| AltraBio | ||
Bridge the gap between biologists, statisticians and informaticians. |
Detect outliers and quality issues that cloud your data. |
Find the needles in your haystack - AltraBio provides expertise in state-of-the-art and innovative life science data analysis and interpretation. |
Place your results in the context of current biomedical knowledge. |
Identify new subgroups in your population. |
|
| Analytisches Zentrum Biopharm | ||
The Analytical Centre of Biopharm, Berlin is a German contract research organization providing services on pharmaceutical analysis and bioanalysis for active compounds in the dosage form. |
AZB carries out stability studies in accordance with ICH,including active compounds which are subject to the Addictive Drugs Act. |
AZB has many years of experience in the quantitative determination of active compounds in a biological matrix. |
Routine analysis is carried out using calibration in the relevant biological matrix, accompanied by a sufficient number of quality control samples. |
Physicochemical properties of intermediates of the chemical industry AZB carries out the determination of physicochemical properties under GLP in accordance with OECD guidelines. |
|
| BioAssayLINK™ | ||
BioAssayLINK is a global online matching tool that provides solutions to your biomedical research and development (R&D) outsourcing/collaboration needs. |
BioAssayLINK's interrelated customer groups consist of companies and consultants working in biotechnology, pharmaceuticals, nutraceuticals and biomedical research. |
We provide timely and valuable laboratory and consultant capability options to customers helping them arrive at better decisions more quickly, advancing their R&D objectives. |
The company's vision is to be the global online leader linking the services and expertise of specialized laboratries with those individuals, teams and organizations involved in discovery, development and delivery of new healthcare products. |
One of our bioassay matching categories is animal models – animal models of disease, for ADME and toxicology, and spontaneous animal models. |
|
| BioScience Business Resources | ||
Array-based technology platforms incorporating novel protein and nucleic acid biomarkers are increasingly being adopted by mainstream diagnostic testing laboratories. |
Automated testing platforms are now available for even the most esoteric assays, enabling the adoption of those tests into routine testing laboratories. |
Biosensor technology is enabling the delivery of diagnostic tests based on novel biomarkers at the point of care. |
| c-LEcta | ||
c-LEcta is located in a biotechnology centre in Leipzig called Bio City. |
c-LEcta uses proprietary technologies with state of the art equipment. |
c-LEcta runs 600 m² of top equipped lab space. |
c-LEcta’s management team is looking forward to discuss the potentials of cooperation with you. |
c-LEcta develops efficient enzyme production processes based on microbial fermentation. |
|
| Cellular Technology Limited | ||
Contracted immune monitoring services. |
Pre-clinical and clinical trial consultation. |
ELISPOT instrumentation and software. |
ELISPOT plate scanning and analysis services. |
PBMC reference samples and serum-free test media. |
|
| Europa Bioproducts | ||
Europa Bioproducts specialises in the distribution of enzymes, kits and reagents used in the characterisation and analysis of the glycosylation patterns of therapeutic proteins and monoclonal antibodies. |
Post-translational modification is important to characterise and monitor because glycosylation has a significant impact on the efficacy, pharmokinetics and safety of the drug. |
Our products allow companies to perform oligosaccharide (glycan) profiling, oligosaccharide (glycan) sequencing and monosaccharide composition. |
We have 2-AA (for monosaccharide composition), 2-AB (for oligosaccharide / glycan profiling) and DMB (for sialic acids) Signal labelling kits. |
Preliminary identification can be achieved by calibrating the column with a 2-AB labelled dextran ladder and comparing retention times to known standards or databases. |
|
| FOCUS Clinical Drug Development | ||
FOCUS Clinical Drug Development is an independent full-service CRO that specialises in exploratory clinical drug development and integrated proof of concept (PoC) packages. |
FOCUS's Neuss Unit has performed >600 Ph I-III studies, more than 80 first-in-man studies (NCE / NBE) and 38 Ph I studies in Japanese subjects since 1997. |
FOCUS headquarters in Neuss, Germany. |
FOCUS can progress your development candidate from preclinical / discovery stage to clinical PoC in the most timely and economical fashion, via an integrated project management. |
FOCUS Immunology offers a range of services for exploratory drug development. |
|
| LanthioPep | ||
LanthioPep increases the in vivo stability of therapeutic and diagnostic imaging peptides by introducing thioether bridges in these peptides. |
LanthioPep’s thioether-bridge technology endows peptides with intrinsic in vivo stability thus creating new prospects for unstable peptide drug candidates. |
LanthioPep has introduced thioether bridges into a broad range of peptides, including peptide hormones and diagnostic imaging peptides. |
LanthioPep is developing its own stabilised peptide therapeutics and diagnostic imaging candidates. |
||
| Micron Group | ||
The Micron Group is an international drug development organisation, specialising in clinical research and development. |
SILK EDC is a SAS-based suite of software for the capture, management and reporting of data from both clinical studies in phases I to IV and registries. |
SILK EDC takes data from both paper and eCRFs, but keeps all the advantages of instant access and reporting. |
Our communications business unit produces reports, publications, posters, slidesets and video. |
Micron can work globally or by continent or country according to the client’s wishes. |
|
| VIBevents | ||
Our fifth annual Pharmacovigilance and Risk Management conference will be held 1-2 December 2009 in Brussels, Belgium. |
The conference will bring together major pharma and biotech manufacturers, as well as regulators, to discuss the important issues of pharmacovigilance and risk management. |
This two-day conference will ensure you effectively manage risk management with current medicines to mitigate any risks to patients. |
